Chemours(US:CC)2021-11-04 16:00Financial Performance - Net sales for Q3 2021 were $1,680 million, a 36.2% increase from $1,233 million in Q3 2020[368] - Gross profit for Q3 2021 was $427 million, up 66.3% from $257 million in Q3 2020[368] - Net income for Q3 2021 reached $214 million, compared to $76 million in Q3 2020, representing a 181.6% increase[368] - Basic earnings per share for Q3 2021 were $1.30, up from $0.46 in Q3 2020, reflecting a 182.6% increase[368] - For the nine months ended September 30, 2021, net sales increased by $1.1 billion (or 31%) to $4.8 billion, compared to $3.6 billion for the same period in 2020[373] - Net sales for the nine months ended September 30, 2021, were $3,033 million, with a gross profit of $350 million[481] Segment Performance - Titanium Technologies segment net sales increased by $296 million (or 48%) to $908 million for the three months ended September 30, 2021, compared to $612 million for the same period in 2020[401] - For the nine months ended September 30, 2021, Titanium Technologies segment net sales increased by $779 million (or 46%) to $2.5 billion, compared to $1.7 billion for the same period in 2020[402] - Thermal & Specialized Solutions segment net sales increased by $25 million (or 9%) to $318 million for the three months ended September 30, 2021, compared to $293 million for the same period in 2020[409] - For the nine months ended September 30, 2021, Thermal & Specialized Solutions segment net sales increased by $130 million (or 16%) to $962 million, compared to $832 million for the same period in 2020[410] - Advanced Performance Materials segment net sales increased by $116 million (or 48%) to $356 million for the three months ended September 30, 2021, compared to $240 million for the same period in 2020[419] - For the nine months ended September 30, 2021, Advanced Performance Materials segment net sales increased by $226 million (or 27%) to $1.1 billion, compared to $825 million for the same period in 2020[420] - Chemical Solutions segment net sales increased by $10 million (or 11%) to $98 million for the three months ended September 30, 2021, compared to $88 million for the same period in 2020[425] Expenses and Costs - Cost of goods sold (COGS) increased by $277 million (or 28%) to $1.3 billion for the three months ended September 30, 2021[375] - Selling, general, and administrative (SG&A) expenses increased by $12 million (or 11%) to $124 million for the three months ended September 30, 2021[376] - Research and development expenses for Q3 2021 were $27 million, up from $22 million in Q3 2020, indicating a focus on innovation[368] - Research and development expenses increased by $5 million (or 23%) to $27 million for the three months ended September 30, 2021[377] - Corporate and Other costs decreased by $1 million (or 2%) to $42 million for Q3 2021, but increased by $36 million (or 29%) to $159 million for the nine months ended September 30, 2021[432] Cash Flow and Liquidity - The Chemours Company generated $606 million in cash flows from operating activities for the nine months ended September 30, 2021, compared to $454 million for the same period in 2020, representing a 33% increase[457] - Cash used for investing activities was $202 million for the nine months ended September 30, 2021, slightly up from $200 million in 2020, primarily due to property, plant, and equipment purchases totaling $194 million[458] - Cash used for financing activities increased to $359 million in the nine months ended September 30, 2021, from $262 million in 2020, driven by $784 million in debt repayments and $123 million in cash dividends paid[459] - The company anticipates sufficient liquidity through at least November 2022, supported by cash generated from operations and existing financing arrangements[361] Debt and Financing - The company issued $650 million in senior unsecured notes due November 2029, with net proceeds used to redeem $750 million in senior notes due May 2025[363] - The Revolving Credit Facility was increased to $900 million and extended to October 2026[364] - The company reduced its debt principal by $107 million in Q3 2021 and issued $650 million of senior unsecured notes due November 2029[441] - Interest expense, net decreased by $8 million (or 15%) to $45 million for the three months ended September 30, 2021[383] Environmental Liabilities and Remediation - Environmental remediation liabilities amounted to $556 million as of September 30, 2021, with $161 million classified as current[446] - The Fayetteville Works site accounted for $351 million of the environmental remediation liabilities as of September 30, 2021, compared to $194 million at the end of 2020[500] - The company expects to spend a total of $208 million over the next three years on the five most significant environmental remediation sites[500] - The Chemours Company accrued an estimated liability of $296 million for on-site remediation costs as of September 30, 2021, which is projected to be paid over approximately 20 years[529] - The company has accrued $205 million for remediation activities in the nine months ended September 30, 2021, with $190 million specifically for on-site remediation at Fayetteville[531] Strategic Initiatives and Future Outlook - The company expects strong volume growth and improved pricing in Titanium Technologies, driven by the Ti-Pure™ Value Stabilization strategy and improved global economic activity[433] - Capital expenditures expectations for 2021 have been reduced by $25 million to approximately $325 million due to project timing[434] - The company aims to reduce absolute operations Scope 1 and Scope 2 greenhouse gas emissions by 60% by 2030[542] - The company plans to reduce air and water process emissions of fluorinated organic chemicals by 99% or more by 2030[542] - The company has committed to reducing landfill volume intensity by 70% by 2030[542]